Non-malignant conditions such as benign prostatic hyperplasia (BPH) and prostatitis can also elevate the PSA levels, particularly within the so-called “gray zone” (2.0–10.0 ng/mL), where the PSA levels for benign and malignant conditions often overlap (4–6). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.